PHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2018
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2018 |
| Quarter | 3 Qtr |
| Quarterly report for the financial period ended | 30 Sep 2018 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Sep 2018
|
30 Sep 2017
|
30 Sep 2018
|
30 Sep 2017
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
587,660
|
574,503
|
1,788,312
|
1,710,764
|
| 2 | Profit/(loss) before tax |
17,603
|
15,271
|
58,280
|
53,198
|
| 3 | Profit/(loss) for the period |
15,305
|
3,890
|
38,660
|
32,899
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
15,051
|
3,580
|
38,031
|
32,023
|
| 5 | Basic earnings/(loss) per share (Subunit) |
5.79
|
1.38
|
14.63
|
12.34
|
| 6 | Proposed/Declared dividend per share (Subunit) |
5.00
|
5.00
|
14.00
|
13.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
2.0100
|
2.0300
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 19 Nov 2018 |
| Category | Financial Results |
| Reference Number | FRA-14112018-00015 |